舒筋汤治疗痹痛型颈椎病临床疗效观察及其安全性评价  

Shujin decoction Bitongkang cervical spondylosis clinical efficacy and safety evaluation

作　　者：陈建斌[1] 

机构地区：[1]连云港市中医院骨伤科,江苏连云港222004

出　　处：《四川中医》2015年第12期149-151,共3页Journal of Sichuan of Traditional Chinese Medicine

摘　　要：目的:观察舒筋汤治疗痹痛型颈椎病患者临床疗效观察及其安全性。方法:80例颈椎病患者根据随机分组法随机分为治疗组(n=40)和对照组(n=40)。对照组采用常规治疗,治疗组在对照组基础上采用舒筋汤治疗。两组疗程均为14天。对比分析两组治疗疗效,治疗前后VAS评分和麻木评分,治疗期间不良反应及随访复发情况。结果:治疗组总有效率显著高于对照组(P<0.05);两组VAS评分治疗后较治疗前显著下降(P<0.05);治疗组VAS评分治疗后显著低于对照组(P<0.05);两组麻木评分治疗后较治疗前显著下降(P<0.05);治疗组麻木评分治疗后显著低于对照组(P<0.05);治疗期间两组均未见明显不良反应;两组复发率比较无统计学差异(P>0.05)。结论:舒筋汤治疗痹痛型颈椎病患者临床疗效显著,安全可靠,具有重要研究价值,值得临床进一步推广应用。Objective： To investigate getting a decoction Bitongkang cervical spondylosis clinical efficacy and safety. Methods： 80 cases of cervical spondylosis were randomly divided into treatment groups based on randomization method（ n =40） and control group（ n = 40）. Control group with conventional therapy,the treatment group were getting a decoction were based on. The treatment lasted 14 day. Comparative analysis before and after treatment efficacy,treatment VAS score and numbness score,adverse reactions during treatment and follow- up recurrence. Results： The total effective rate was significantly higher（ P 〈0. 05）; the two groups after the treatment,the VAS score decreased significantly（ P 〈0. 05）; VAS scores after treatment in treatment group was significantly lower than the control group（ P 〈0. 05）; two numbness score after treatment than before treatment significantly decreased（ P 〈0. 05）; after treatment,the treatment group numbness score significantly lower than the control group（ P 〈0. 05）; the two groups during treatment showed no significant adverse reactions; two recurrence There was no significant difference rates（ P 〉0. 05）. Conclusion： Shujin decoction Bitongkang cervical spondylosis significant clinical effect,safe and reliable,an important research value,worthy of further clinical application.

关 键 词：舒筋汤 痹痛型 颈椎病 疗效 安全性 

分 类 号：R681.55[医药卫生—骨科学]